GENE logo.png
Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
11 sept. 2024 08h15 HE | Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
GENE logo.png
Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
15 août 2024 08h00 HE | Genetic Technologies Ltd
CHARLOTTE, N.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious...
GENE logo.png
Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15
09 août 2024 08h00 HE | Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven...
GENE logo.png
Genetic Technologies Strategic Restructure Driving USA Sales Growth
26 juil. 2024 08h00 HE | Genetic Technologies Ltd
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious...
GENE logo.png
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
16 juil. 2024 08h00 HE | Genetic Technologies Ltd
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and...
GENE logo.png
GeneType to Enter Canadian and New Zealand Markets
09 juil. 2024 08h00 HE | Genetic Technologies Ltd
GeneType to Enter Canadian and New Zealand Markets
GENE logo.png
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
25 juin 2024 08h00 HE | Genetic Technologies Ltd
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
GENE logo.png
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
21 juin 2024 08h00 HE | Genetic Technologies Ltd
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
GENE logo.png
Genetic Technologies Expands Operational Capacity in North America
18 juin 2024 08h00 HE | Genetic Technologies Ltd
GeneType Expands Operational Capacity in North America
GENE logo.png
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
05 juin 2024 08h00 HE | Genetic Technologies Ltd
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test